PROTAC Library

Loading...
E3 Ligase
Target
Molecular Weight
to
Your selection
  • Your selection
Structure Catalog Product Name CAS E3 Ligase Target Inquiry
1-(3-Bromo-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)-N-(4-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)butyl)piperidine-2-carboxamide BPL-201133 1-(3-Bromo-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)-N-(4-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)butyl)piperidine-2-carboxamide 2447066-17-1

CRBN

PD-L1

Inquiry

Molecular Weight: 820.79

Molecular Formula: C44H46BrN5O6

Boiling Point: 987.3±65.0°C at 760 Torr

Density: 1.381±0.06 g/cm3

Description: It is a resorcinol diphenyl ether-based PROTAC-like molecule as a dual inhibitor and degrader of PD-L1.

N1-(2-(1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carboxamido)ethyl)-N5-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)glutaramide BPL-201134 N1-(2-(1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carboxamido)ethyl)-N5-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)glutaramide 2447066-18-2

CRBN

PD-L1

Inquiry

Molecular Weight: 992.53

Molecular Formula: C55H54ClN7O9

Boiling Point: 1193.9±65.0°C at 760 Torr

Density: 1.40±0.1 g/cm3

Description: It is a resorcinol diphenyl ether-based PROTAC-like molecule as a dual inhibitor and degrader of PD-L1.

N1-(4-(1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carboxamido)butyl)-N5-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)glutaramide BPL-201135 N1-(4-(1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carboxamido)butyl)-N5-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)glutaramide 2447066-19-3

CRBN

PD-L1

Inquiry

Molecular Weight: 1020.58

Molecular Formula: C57H58ClN7O9

Boiling Point: 1204.2±65.0°C at 760 Torr

Density: 1.38±0.1 g/cm3

Description: It is a resorcinol diphenyl ether-based PROTAC-like molecule as a dual inhibitor and degrader of PD-L1.

N1-(3-(1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carboxamido)propyl)-N5-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)glutaramide BPL-201136 N1-(3-(1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carboxamido)propyl)-N5-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)glutaramide

CRBN

PD-L1

Inquiry

Molecular Weight: 1006.56

Molecular Formula: C56H56ClN7O9

Description: It is a resorcinol diphenyl ether-based PROTAC-like molecule as a dual inhibitor and degrader of PD-L1.

N1-(5-(1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carboxamido)pentyl)-N5-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)glutaramide BPL-201137 N1-(5-(1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carboxamido)pentyl)-N5-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)glutaramide 2447066-21-7

CRBN

PD-L1

Inquiry

Molecular Weight: 1034.61

Molecular Formula: C58H60ClN7O9

Boiling Point: 1207.0±65.0°C at 760 Torr

Density: 1.37±0.1 g/cm3

Description: It is a resorcinol diphenyl ether-based PROTAC-like molecule as a dual inhibitor and degrader of PD-L1.

N1-(2-(1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carboxamido)ethyl)-N5-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)glutaramide BPL-201138 N1-(2-(1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carboxamido)ethyl)-N5-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)glutaramide 2447066-22-8

CRBN

PD-L1

Inquiry

Molecular Weight: 992.53

Molecular Formula: C55H54ClN7O9

Boiling Point: 1196.7±65.0°C at 760 Torr

Density: 1.40±0.1 g/cm3

Description: It is a resorcinol diphenyl ether-based PROTAC-like molecule as a dual inhibitor and degrader of PD-L1.

5-(4-(1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carbonyl)piperazin-1-yl)-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)-5-oxopentanamide BPL-201139 5-(4-(1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carbonyl)piperazin-1-yl)-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)-5-oxopentanamide 2447066-23-9

CRBN

PD-L1

Inquiry

Molecular Weight: 1018.57

Molecular Formula: C57H56ClN7O9

Density: 1.42±0.1 g/cm3

Description: It is a resorcinol diphenyl ether-based PROTAC-like molecule as a dual inhibitor and degrader of PD-L1.

4-(4-(1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carbonyl)piperazin-1-yl)-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)-4-oxobutanamide BPL-201140 4-(4-(1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carbonyl)piperazin-1-yl)-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)-4-oxobutanamide 2447066-24-0

CRBN

PD-L1

Inquiry

Molecular Weight: 1004.54

Molecular Formula: C56H54ClN7O9

Density: 1.43±0.1 g/cm3

Description: It is a resorcinol diphenyl ether-based PROTAC-like molecule as a dual inhibitor and degrader of PD-L1.

1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)-N-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethyl)piperidine-2-carboxamide BPL-201141 1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)-N-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethyl)piperidine-2-carboxamide 2447066-25-1

CRBN

PD-L1

Inquiry

Molecular Weight: 879.41

Molecular Formula: C50H47ClN6O7

Boiling Point: 1061.9±65.0°C at 760 Torr

Density: 1.40±0.1 g/cm3

Description: It is a resorcinol diphenyl ether-based PROTAC-like molecule as a dual inhibitor and degrader of PD-L1.

1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)-N-(3-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)propyl)piperidine-2-carboxamide BPL-201142 1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)-N-(3-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)propyl)piperidine-2-carboxamide 2447066-26-2

CRBN

PD-L1

Inquiry

Molecular Weight: 893.44

Molecular Formula: C51H49ClN6O7

Boiling Point: 1068.0±65.0°C at 760 Torr

Density: 1.39±0.1 g/cm3

Description: It is a resorcinol diphenyl ether-based PROTAC-like molecule as a dual inhibitor and degrader of PD-L1.

1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)-N-(4-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)butyl)piperidine-2-carboxamide BPL-201143 1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)-N-(4-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)butyl)piperidine-2-carboxamide 2447066-27-3

CRBN

PD-L1

Inquiry

Molecular Weight: 907.47

Molecular Formula: C52H51ClN6O7

Boiling Point: 1074.3±65.0°C at 760 Torr

Density: 1.38±0.1 g/cm3

Description: It is a resorcinol diphenyl ether-based PROTAC-like molecule as a dual inhibitor and degrader of PD-L1.

1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)-N-(5-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)pentyl)piperidine-2-carboxamide BPL-201144 1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)-N-(5-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)pentyl)piperidine-2-carboxamide 2447066-29-5

CRBN

PD-L1

Inquiry

Molecular Weight: 921.49

Molecular Formula: C53H53ClN6O7

Boiling Point: 1078.3±65.0°C at 760 Torr

Density: 1.37±0.1 g/cm3

Description: It is a resorcinol diphenyl ether-based PROTAC-like molecule as a dual inhibitor and degrader of PD-L1.

1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)-N-(6-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)hexyl)piperidine-2-carboxamide BPL-201145 1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)-N-(6-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)hexyl)piperidine-2-carboxamide 2447066-30-8

CRBN

PD-L1

Inquiry

Molecular Weight: 935.52

Molecular Formula: C54H55ClN6O7

Boiling Point: 1082.4±65.0°C at 760 Torr

Density: 1.35±0.1 g/cm3

Description: It is a resorcinol diphenyl ether-based PROTAC-like molecule as a dual inhibitor and degrader of PD-L1.

N1-(2-(1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carboxamido)ethyl)-N4-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)succinamide BPL-201146 N1-(2-(1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)piperidine-2-carboxamido)ethyl)-N4-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)succinamide 2447066-31-9

CRBN

PD-L1

Inquiry

Molecular Weight: 978.50

Molecular Formula: C54H52ClN7O9

Boiling Point: 1188.3±65.0°C at 760 Torr

Density: 1.42±0.1 g/cm3

Description: It is a resorcinol diphenyl ether-based PROTAC-like molecule as a dual inhibitor and degrader of PD-L1.

1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)-N-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-2-oxoethoxy)acetamido)ethyl)piperidine-2-carboxamide BPL-201147 1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((2-methyl-[1,1'-biphenyl]-3-yl)methoxy)benzyl)-N-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-2-oxoethoxy)acetamido)ethyl)piperidine-2-carboxamide 2447066-32-0

CRBN

PD-L1

Inquiry

Molecular Weight: 994.50

Molecular Formula: C54H52ClN7O10

Boiling Point: 1190.4±65.0°C at 760 Torr

Density: 1.43±0.1 g/cm3

Description: It is a resorcinol diphenyl ether-based PROTAC-like molecule as a dual inhibitor and degrader of PD-L1.

N1-(2-(1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)piperidine-2-carboxamido)ethyl)-N5-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)glutaramide BPL-201148 N1-(2-(1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)piperidine-2-carboxamido)ethyl)-N5-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)glutaramide 2447066-33-1

CRBN

PD-L1

Inquiry

Molecular Weight: 1050.57

Molecular Formula: C57H56ClN7O11

Density: 1.44±0.1 g/cm3

Description: It is a resorcinol diphenyl ether-based PROTAC-like molecule as a dual inhibitor and degrader of PD-L1.

N1-(2-(1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)piperidine-2-carboxamido)ethyl)-N5-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)glutaramide BPL-201149 N1-(2-(1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)piperidine-2-carboxamido)ethyl)-N5-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)glutaramide 2447066-34-2

CRBN

PD-L1

Inquiry

Molecular Weight: 1050.57

Molecular Formula: C57H56ClN7O11

Density: 1.44±0.1 g/cm3

Description: It is a resorcinol diphenyl ether-based PROTAC-like molecule as a dual inhibitor and degrader of PD-L1.

1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)-N-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-2-oxoethoxy)acetamido)ethyl)piperidine-2-carboxamide BPL-201150 1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)-N-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)-2-oxoethoxy)acetamido)ethyl)piperidine-2-carboxamide 2447066-35-3

CRBN

PD-L1

Inquiry

Molecular Weight: 1052.54

Molecular Formula: C56H54ClN7O12

Density: 1.46±0.1 g/cm3

Description: It is a resorcinol diphenyl ether-based PROTAC-like molecule as a dual inhibitor and degrader of PD-L1.

N1-(2-(1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)piperidine-2-carboxamido)ethyl)-N4-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)succinamide BPL-201151 N1-(2-(1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)piperidine-2-carboxamido)ethyl)-N4-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)succinamide 2447066-36-4

CRBN

PD-L1

Inquiry

Molecular Weight: 1036.54

Molecular Formula: C56H54ClN7O11

Density: 1.45±0.1 g/cm3

Description: It is a resorcinol diphenyl ether-based PROTAC-like molecule as a dual inhibitor and degrader of PD-L1.

4-(4-(1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)piperidine-2-carbonyl)piperazin-1-yl)-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)-4-oxobutanamide BPL-201152 4-(4-(1-(5-Chloro-2-((3-cyanobenzyl)oxy)-4-((3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-2-methylbenzyl)oxy)benzyl)piperidine-2-carbonyl)piperazin-1-yl)-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)-4-oxobutanamide 2447066-38-6

CRBN

PD-L1

Inquiry

Molecular Weight: 1062.58

Molecular Formula: C58H56ClN7O11

Density: 1.46±0.1 g/cm3

Description: It is a resorcinol diphenyl ether-based PROTAC-like molecule as a dual inhibitor and degrader of PD-L1.

We invite you to contact us at or through our contact form above for more information about our services and products.

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Inquiry Basket